Consolidated Statements of Cash Flows - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2021	Mar. 31, 2020
Cash Flows from Operating Activities
Net loss		$ (63.9)	$ (171.9)
Income (loss) from discontinued operations, net of tax		5.0	(4.7)
Loss from continuing operations, net of tax		(68.9)	(167.2)
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:
Depreciation		13.9	16.3
Amortization		6.0	6.0
Provision for doubtful accounts		17.4	29.7
Provision for obsolescence		7.7	18.6
Share-based compensation		0.6	16.9
Foreign exchange losses (gains)		0.5	21.9
Deferred income taxes		(1.6)	8.0
Impairment loss on assets		0.0	0.7
Other		0.3	10.3
Changes in assets and liabilities:
Accounts receivable		(18.4)	(18.3)
Inventories		(29.5)	(32.8)
Prepaid expenses and other		(21.6)	1.0
Accounts payable and accrued liabilities		(76.8)	(174.0)
Income and other taxes		0.8	(24.2)
Noncurrent assets and liabilities		0.7	(12.7)
Net cash used by operating activities of continuing operations		(168.9)	(299.8)
Cash Flows from Investing Activities
Capital expenditures		(13.8)	(7.3)
Disposal of assets		1.1	2.4
Net cash used by investing activities of continuing operations		(12.7)	(4.9)
Cash Flows from Financing Activities
Cash dividends		0.0	(8.6)
Debt, net (maturities of three months or less)		7.9	1.8
Proceeds from debt		76.5	0.0
Repayment of debt		(12.6)	0.0
Settlement of stock options		0.0	(25.8)
Settlement of derivative contracts		(4.8)	5.7
Other financing activities		0.0	(0.6)
Net cash provided (used) by financing activities of continuing operations		67.0	(27.5)
Net cash used by operating activities of discontinued operations		(1.5)	(6.7)
Net cash used by discontinued operations		(1.5)	(6.7)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash		(17.6)	(20.8)
Net decrease in cash and cash equivalents, and restricted cash		(133.7)	(359.7)
Cash and cash equivalents, and restricted cash at beginning of year	[1]	373.4	661.1
Cash and cash equivalents, and restricted cash at end of period	[1]	$ 239.7	$ 301.4

[1] The balance at the beginning of the three-month period ended March 31, 2021 includes cash and cash equivalents of $.7 classified as Assets held for sale in the Company's Consolidated Balance Sheets. The balance at the beginning of the three-month period ended March 31, 2020 includes Long-term restricted cash of $7.6 which is presented in other assets in our Consolidated Balance Sheets.